Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
2020-01-01 Personeni, Nicola; Lleo, Ana; Pressiani, Tiziana; Colapietro, Francesca; Openshaw, Mark Robert; Stavraka, Chara; Pouptsis, Athanasios; Pinato, David James; Rimassa, Lorenza
Cabozantinib for the treatment of hepatocellular carcinoma
2019-01-01 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population
2025-01-01 Rimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC)
2018-01-01 Rimassa, L; Assenat, E; Peck-Radosavljevic, M; Pracht, M; Zagonel, V; Mathurin, P; Rota-Caremoli, E; Porta, C; Daniele, B; Bolondi, L; Mazzaferro, V; Harris, W; Damjanov, N; Pastorelli, D; Reig, M; Knox, J; Negri, F; Trojan, J; López López, C; Personeni, N; Decaens, T; Dupuy, M; Sieghart, W; Abbadessa, G; Schwartz, B; Lamar, M; Goldberg, T; Shuster, D; Santoro, A; Bruix, J.
Reply to Y. Pointreau et al
2012-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
2019-01-01 Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma
2013-01-01 Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A.
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer
2019-01-01 Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C.
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients
2022-01-01 Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A.
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011-01-01 Personeni, N.; Torzilli, G.; Santoro, A.
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
2021-01-01 Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias
Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
2020-01-01 Personeni, N; Pressiani, T; Rimassa, L
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma
In corso di stampa Personeni, N; Pressiani, T; Rimassa, L
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
2010-01-01 Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options | 1-gen-2020 | Personeni, Nicola; Lleo, Ana; Pressiani, Tiziana; Colapietro, Francesca; Openshaw, Mark Robert; Stavraka, Chara; Pouptsis, Athanasios; Pinato, David James; Rimassa, Lorenza | |
| Cabozantinib for the treatment of hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A | |
| The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population | 1-gen-2025 | Rimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea | |
| Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC) | 1-gen-2018 | Rimassa, L; Assenat, E; Peck-Radosavljevic, M; Pracht, M; Zagonel, V; Mathurin, P; Rota-Caremoli, E; Porta, C; Daniele, B; Bolondi, L; Mazzaferro, V; Harris, W; Damjanov, N; Pastorelli, D; Reig, M; Knox, J; Negri, F; Trojan, J; López López, C; Personeni, N; Decaens, T; Dupuy, M; Sieghart, W; Abbadessa, G; Schwartz, B; Lamar, M; Goldberg, T; Shuster, D; Santoro, A; Bruix, J. | |
| Reply to Y. Pointreau et al | 1-gen-2012 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| Targeted agents for second-line treatment of advanced hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
| A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma | 1-gen-2013 | Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A. | |
| Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer | 1-gen-2019 | Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S | |
| Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C. | |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients | 1-gen-2022 | Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto | |
| Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A. | |
| Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? | 1-gen-2011 | Personeni, N.; Torzilli, G.; Santoro, A. | |
| Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza | |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC | 1-gen-2021 | Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias | |
| Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma | 1-gen-2020 | Personeni, N; Pressiani, T; Rimassa, L | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma | In corso di stampa | Personeni, N; Pressiani, T; Rimassa, L | |
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | 1-gen-2010 | Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista70079
- 7 Altro1
Data di pubblicazione
- In corso di stampa70
- 2020 - 202615412
- 2010 - 201922876
- 2000 - 200918271
- 1990 - 19998867
- 1980 - 19893843
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI917
- Elsevier Ltd721
- Elsevier B.V.608
- MDPI AG496
- Elsevier370
- Springer306
- John Wiley and Sons Inc296
- Springer Science and Business Med...276
- Multidisciplinary Digital Publish...271
- Elsevier Inc.248
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE930
- PLOS ONE375
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- AREA262
- SCIENTIFIC REPORTS259
- INTERNATIONAL JOURNAL OF MOLECULA...186
- DOCTOR. OS183
- ACTA BIOMEDICA179
- NUTRIENTS172
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2896
- Female1591
- Male1487
- Middle Aged900
- Adult893
- Aged756
- Animals651
- Italy580
- Medicine (all)463
- COVID-19447
Lingua
- eng42158
- ita8972
- fre231
- spa121
- ger98
- und58
- enm49
- rus40
- grc32
- por30
Accesso al fulltext
- no fulltext56792
- reserved8055
- open3743
- partially open810
- restricted667
- mixed13